Lapsi Health is developing the new generation of digital biomarkers based on auscultatory sound. The data used as a biomarker has to be quantifiable and objective and the company’s novel technology greatly enhances its usage in medicine, relating it to the health-disease process for prognostic, diagnostic and therapeutic purposes.

 

    • Founding year:
2022

    • Development phase:
Prototype/beta testing

    • Funding stage:
Pre-seed/Seed

    • Website:

    • Contact person info:
info(at)lapsihealth.com

    • Team members:
6

    • Article:
Read an article about Lapsi Health.